ArticleCancers2022
Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
Haosheng Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it
ArticleCancers2022
Haosheng Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.